MedPath
HSA Approval

BICAMED 50 BICALUTAMIDE TABLETS 50mg

SIN14824P

BICAMED 50 BICALUTAMIDE TABLETS 50mg

BICAMED 50 BICALUTAMIDE TABLETS 50mg

August 4, 2015

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence HolderMEDICELL PHARMACEUTICAL (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

L02BB03

bicalutamide

Manufacturer Information

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Hetero Labs Limited

Active Ingredients

Bicalutamide

50.000 mg

Bicalutamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BICAMED 50 BICALUTAMIDE TABLETS 50mg - HSA Approval | MedPath